Asia CRO Market Research Report Forecast to 2032

Asia CRO Market is expected to register a significant CAGR of 12.87% during the review period. The increasing outsourcing of R&D and the growing complexity of drug development are boosting the demand for CRO services. Moreover, the rising prevalence of chronic diseases and government support for R&D are also fueling the growth of the market. However, a lack of experienced and skilled professionals to run tech-based equipment in CRO laboratories is hindering the growth of the Asia CRO market. Additionally, increasing number of clinical trials, growing demand for precision medicine, and the high incorporation of artificial intelligence (AI) and machine learning (ML) in CROs are creating lucrative opportunities for the market during the forecast period.

Contract research organization (CRO) is a company that provides research services to other companies on a contract basis. CROs are commonly used by pharmaceutical, biotechnology, and medical device companies to outsource certain aspects of their research and development (R&D) process. CROs can offer several benefits to sponsors, including access to a wide range of expertise in drug and device development, help sponsors reduce the cost of R&D by offering economies of scale, and provide sponsors with the flexibility to scale their R&D operations up or down as needed.

Market Segmentation

Based on the service type, the market has been segmented into pharmacovigilance, clinical research services, formulation, development service, laboratory services, consulting services, data management services, and interactive web response systems (IWRS) services.

On the basis of the application, the market has been segmented into vaccines, oncology, cardiovascular, respiratory, central nervous system, diabetes, autoimmune disorders, infectious diseases, and others.

On the basis of end user, Asia CRO market has been segmented into pharmaceutical and biopharmaceutical companies, medical device companies, academic institute, and others.

Regional Analysis

Asia-pacific contract research organization (CRO) market consists of Singapore, Malaysia, Thailand, Taiwan, South Korea, Philippines, Sri Lanka, Bangladesh, Vietnam and Rest of Asia-Pacific. The South Korea accounted for largest market share in 2022 and registered the highest CAGR during the forecast period.

In recent years, the Asia-Pacific region has become the hot spot for conducting clinical trials. As per Pharma Intelligence UK Limited (UK), the Asia-Pacific (APAC) region accounted for 50% of clinical trial activity globally in 2021. Moreover, in APAC, South Korea accounted for approximately 13% of the region in 2021.

Major Players

ClinActis (Singapore), OrciTrials (Singapore), Celero (Singapore), Expecto Health Science (Singapore), ACROSS Global Alliance Pte. Ltd. (Singapore), ClinActis Pte. Ltd. (Singapore), TMC Solutions Pte Ltd (Singapore), Experimental Drug Development Centre (Singapore), Info Kinetics Sdn Bhd (Penang, Malaysia), Clinical Research Malaysia (Kuala Lumpur, Malaysia), ACLIRES Bangkok Ltd. (Bangkok, Thailand), Asia Global Research Co., Ltd. (Bangkok, Thailand), Clinixir (Bangkok, Thailand), LSK Global Pharma Services Co., Ltd. (Seoul, South Korea), ADM Korea Inc. (Seoul, South Korea), Synex Consulting Ltd. (Seoul, South Korea), Seoul CRO (Seoul, South Korea), C&R RESEARCH Inc. (Seoul, South Korea),nMedi Helpline (Seoul, South Korea), Total Trial Management Consulting Co. Ltd. (Taipei, Taiwan), T-TOP Clinical Research Co., Ltd. (Taiwan), Efficient Pharma Management Corp. (EffPha) (Taiwan), Bangladesh Clinical Trials Limited (Dhaka, Bangladesh), Medica Innova Co,. Ltd. (Bangkok, Thailand), AMARC (Bangkok, Thailand), A2 Healthcare Taiwan Corp. (Taiwan), PROMEDIS (Seoul, South Korea), PiVOT (Pasig, Philippines), Pharmalytics Corporation (Cavite, Philippines), and RemediumOne (Colombo, Sri Lanka).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVESYSTEM
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 3.6.1 BOTTOM-UP APPROACH
- 3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW
4.2 DRIVERS
- 4.2.1 RISING SPENDING ON R&D
- 4.2.2 GROWING NUMBER OF CLINICAL TRIALS OWING TO LARGE AND DIVERSE PATIENT POPULATIONS
- 4.2.3 COST-EFFECTIVE CRO SERVICES
4.3 RESTRAINTS
- 4.3.1 LACK OF EXPERIENCED AND SKILLED PROFESSIONALS
4.4 OPPORTUNITY
- 4.4.1 GROWING DEMAND FOR INNOVATIVE HEALTHCARE SOLUTIONS
4.5 IMPACT OF COVID-19 ON CONTRACT RESEARCH ORGANIZATION MARKET
- 4.5.1 IMPACT ON COST
- 4.5.2 IMPACT ON SERVICES
- 4.5.3 IMPACT ON AVAILABILITY OF WORKFORCE
- 4.5.4 KEY STRATEGIES
4.6 ANALYSIS OF REGULATORY LANDSCAPE BY COUNTRY

5 ASIA CRO MARKET, BY SERVICE TYPE

5.1 OVERVIEW
5.2 CLINICAL RESEARCH SERVICES
5.3 FORMULATION DEVELOPMENT SERVICE
5.4 PHARMACOVIGILANCE SERVICES
5.5 LABORATORY SERVICES
5.6 CONSULTING SERVICES
5.7 BIOSTATISTICS SERVICES
5.8 MEDICAL WRITING SERVICES
5.9 DATA MANAGEMENT SERVICES
5.10 INTERACTIVE WEB RESPONSE SYSTEMS (IWRS) SERVICES

6 ASIA CRO MARKET, BY APPLICATION

6.1 OVERVIEW
6.2 VACCINES
6.3 ONCOLOGY
6.4 CARDIOVASCULAR
6.5 RESPIRATORY
6.6 CENTRAL NERVOUS SYSTEM
6.7 GASTROENTEROLOGY
6.8 DIABETES
6.9 AUTOIMMUNE DISORDERS
6.10 INFECTIOUS DISEASES
6.11 OTHERS

7 ASIA CRO MARKET, BY END USER

7.1 OVERVIEW
7.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
7.3 MEDICAL DEVICE COMPANIES
7.4 ACADEMIC INSTITUTES
7.5 OTHERS

8 ASIA CRO MARKET, BY COUNTRY

8.1 OVERVIEW
8.2 SOUTH KOREA
8.3 SINGAPORE
8.4 THAILAND
8.5 TAIWAN
8.6 MALAYSIA
8.7 PHILIPPINES
8.8 VIETNAM
8.9 BANGLADESH
8.10 SRI LANKA

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW
9.2 COMPETITIVE BENCHMARKING
9.3 MARKET SHARE ANALYSIS, 2022-2023 (%)
9.4 MAJOR PLAYERS SALES ANALYSIS
- 9.4.1 SALES
9.5 LIST OF EMERGING CROS IN KEY COUNTRIES
9.6 TOP 5 EMERGING CROS IN ASIA
- 9.6.1 LSK GLOBAL PHARMA SERVICES
- 9.6.2 EXPECTO HEALTH SCIENCE
- 9.6.3 MEDI HELP LINE CO., LTD.
- 9.6.4 C&R RESEARCH INC.
- 9.6.5 ADM KOREA INC
9.7 LIST OF DATA MANAGEMENT SOFTWARE USED BY CROS IN ASIA
9.8 TOTAL NUMBER OF CLINICAL TRIALS BY PHASE FOR MAJOR ASIA COUNTRIES (2019-2023)
9.9 BIBLIOGRAPHY

10 COMPANY PROFILES

10.1 SYNEOS HEALTH
- 10.1.1 COMPANY OVERVIEW
- 10.1.2 FINANCIAL OVERVIEW
- 10.1.3 SERVICES OFFERED
- 10.1.4 KEY DEVELOPMENTS
- 10.1.5 KEY STRATEGIES
10.2 PAREXEL INTERNATIONAL (MA) CORPORATION
- 10.2.1 COMPANY OVERVIEW
- 10.2.2 FINANCIAL OVERVIEW
- 10.2.3 SERVICES OFFERED
- 10.2.4 KEY DEVELOPMENTS
- 10.2.5 SWOT ANALYSIS
- 10.2.6 KEY STRATEGIES
10.3 MEDPACE
- 10.3.1 COMPANY OVERVIEW
- 10.3.2 FINANCIAL OVERVIEW
- 10.3.3 SERVICES OFFERED
- 10.3.4 KEY DEVELOPMENTS
- 10.3.5 KEY STRATEGIES
10.4 CMIC HOLDINGS CO., LTD
- 10.4.1 COMPANY OVERVIEW
- 10.4.2 FINANCIAL OVERVIEW
- 10.4.3 SERVICES OFFERED
- 10.4.4 KEY DEVELOPMENTS
- 10.4.5 KEY STRATEGIES
10.5 TIGERMED
- 10.5.1 COMPANY OVERVIEW
- 10.5.2 FINANCIAL OVERVIEW
- 10.5.3 SERVICES OFFERED
- 10.5.4 KEY DEVELOPMENTS
- 10.5.5 KEY STRATEGIES
10.6 IQVIA HOLDING, INC.
- 10.6.1 COMPANY OVERVIEWS
- 10.6.2 FINANCIAL OVERVIEW
- 10.6.3 SERVICES OFFERED
- 10.6.4 KEY DEVELOPMENTS
- 10.6.5 SWOT ANALYSIS
- 10.6.6 KEY STRATEGIES
10.7 ICON PLC
- 10.7.1 COMPANY OVERVIEW
- 10.7.2 FINANCIAL OVERVIEW
- 10.7.3 SERVICES OFFERED
- 10.7.4 KEY DEVELOPMENTS
- 10.7.5 SWOT ANALYSIS
- 10.7.6 KEY STRATEGIES
10.8 LABORATORY CORPORATION OF AMERICA HOLDINGS
- 10.8.1 COMPANY OVERVIEW
- 10.8.2 FINANCIAL OVERVIEW
- 10.8.3 SERVICES OFFERED
- 10.8.4 KEY DEVELOPMENTS
- 10.8.5 SWOT ANALYSIS
- 10.8.6 KEY STRATEGIES

10.9 PPD INC.
- 10.9.1 COMPANY OVERVIEW
- 10.9.2 FINANCIAL OVERVIEW
- 10.9.3 SERVICES OFFERED
- 10.9.4 KEY DEVELOPMENTS
- 10.9.5 SWOT ANALYSIS
- 10.9.6 KEY STRATEGIES
10.10 WUXI APPTEC
- 10.10.1 COMPANY OVERVIEW
- 10.10.2 FINANCIAL OVERVIEW
- 10.10.3 SERVICES OFFERED
- 10.10.4 KEY DEVELOPMENTS
- 10.10.5 KEY STRATEGIES

11 APPENDIX

11.1 REFERENCES
11.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 19
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 22
TABLE 3 KEY STRATEGIES 32
TABLE 1 REGULATORY LANDSCAPE BY COUNTRY 34
TABLE 2 ASIA CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 46
TABLE 3 ASIA CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2019-2032 (USD MILLION) 47
TABLE 4 ASIA CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY COUNTRY, 2019-2032 (USD MILLION) 48
TABLE 5 ASIA CRO MARKET, FOR PHARMACOVIGILANCE SERVICES, BY COUNTRY, 2019-2032 (USD MILLION) 49
TABLE 6 ASIA CRO MARKET, FOR LABORATORY SERVICES, BY COUNTRY, 2019-2032 (USD MILLION) 50
TABLE 7 ASIA CRO MARKET, FOR CONSULTING SERVICES, BY COUNTRY, 2019-2032 (USD MILLION) 51
TABLE 8 ASIA CRO MARKET, FOR BIOSTATISTICS SERVICES, BY COUNTRY, 2019-2032 (USD MILLION) 52
TABLE 9 ASIA CRO MARKET, FOR MEDICAL WRITING SERVICES, BY COUNTRY, 2019-2032 (USD MILLION) 53
TABLE 10 ASIA CRO MARKET, FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2019-2032 (USD MILLION) 54
TABLE 11 ASIA CRO MARKET, FOR INTERACTIVE WEB RESPONSE SYSTEMS (IWRS) SERVICES, BY COUNTRY, 2019-2032 (USD MILLION) 55
TABLE 12 ASIA CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 60
TABLE 13 ASIA CRO MARKET, FOR VACCINES, BY COUNTRY, 2019-2032 (USD MILLION) 61
TABLE 14 ASIA CRO MARKET, FOR ONCOLOGY, BY COUNTRY, 2019-2032 (USD MILLION) 62
TABLE 15 ASIA CRO MARKET, FOR CARDIOVASCULAR, BY COUNTRY, 2019-2032 (USD MILLION) 63
TABLE 16 ASIA CRO MARKET, FOR RESPIRATORY, BY COUNTRY, 2019-2032 (USD MILLION) 64
TABLE 17 ASIA CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY COUNTRY, 2019-2032 (USD MILLION) 65
TABLE 18 ASIA CRO MARKET, FOR GASTROENTEROLOGY, BY COUNTRY, 2019-2032 (USD MILLION) 66
TABLE 19 ASIA CRO MARKET, FOR DIABETES, BY COUNTRY, 2019-2032 (USD MILLION) 67
TABLE 20 ASIA CRO MARKET, FOR AUTOIMMUNE DISORDERS, BY COUNTRY, 2019-2032 (USD MILLION) 68
TABLE 21 ASIA CRO MARKET, FOR INFECTIOUS DISEASES, BY COUNTRY, 2019-2032 (USD MILLION) 69
TABLE 22 ASIA CRO MARKET, FOR OTHERS, BY COUNTRY, 2019-2032 (USD MILLION) 70
TABLE 23 ASIA CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 73
TABLE 24 ASIA CRO MARKET, FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2032 (USD MILLION) 75
TABLE 25 ASIA CRO MARKET, FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2019-2032 (USD MILLION) 76
TABLE 26 ASIA CRO MARKET, FOR ACADEMIC INSTITUTES, BY COUNTRY, 2019-2032 (USD MILLION) 77
TABLE 27 ASIA CRO MARKET, FOR ACADEMIC INSTITUTES, BY COUNTRY, 2019-2032 (USD MILLION) 78
TABLE 28 ASIA: CRO MARKET, BY COUNTRY, 2019-2032 (USD MILLION) 82
TABLE 29 SOUTH KOREA: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 84
TABLE 30 SOUTH KOREA: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019-2032 (USD MILLION) 85
TABLE 31 SOUTH KOREA: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019-2032 (USD MILLION) 86
TABLE 32 SOUTH KOREA: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019-2032 (USD MILLION) 87
TABLE 33 SOUTH KOREA: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019-2032 (USD MILLION) 88
TABLE 34 SOUTH KOREA: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 89
TABLE 35 SOUTH KOREA: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 90
TABLE 36 SOUTH KOREA: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 91
TABLE 37 SINGAPORE: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 93
TABLE 38 SINGAPORE: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019-2032 (USD MILLION) 94
TABLE 39 SINGAPORE: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019-2032 (USD MILLION) 95
TABLE 40 SINGAPORE: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019-2032 (USD MILLION) 96
TABLE 41 SINGAPORE: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019-2032 (USD MILLION) 97
TABLE 42 SINGAPORE: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 98
TABLE 43 SINGAPORE: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 99
TABLE 44 SINGAPORE: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 100
TABLE 45 THAILAND: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 102
TABLE 46 THAILAND: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019-2032 (USD MILLION) 103
TABLE 47 THAILAND: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019-2032 (USD MILLION) 104
TABLE 48 THAILAND: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019-2032 (USD MILLION) 105
TABLE 49 THAILAND: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019-2032 (USD MILLION) 106
TABLE 50 THAILAND: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 107
TABLE 51 THAILAND: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 108
TABLE 52 THAILAND: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 109
TABLE 53 TAIWAN: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 111
TABLE 54 TAIWAN: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019-2032 (USD MILLION) 112
TABLE 55 TAIWAN: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019-2032 (USD MILLION) 113
TABLE 56 TAIWAN: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019-2032 (USD MILLION) 114
TABLE 57 TAIWAN: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019-2032 (USD MILLION) 115
TABLE 58 TAIWAN: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 116
TABLE 59 TAIWAN: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 117
TABLE 60 TAIWAN: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 118
TABLE 61 MALAYSIA: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 120
TABLE 62 MALAYSIA: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019-2032 (USD MILLION) 121
TABLE 63 MALAYSIA: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019-2032 (USD MILLION) 122
TABLE 64 MALAYSIA: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019-2032 (USD MILLION) 123
TABLE 65 MALAYSIA: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019-2032 (USD MILLION) 124
TABLE 66 MALAYSIA: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 125
TABLE 67 MALAYSIA: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 126
TABLE 68 MALAYSIA: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 127
TABLE 69 PHILIPPINES: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 129
TABLE 70 PHILIPPINES: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019-2032 (USD MILLION) 130
TABLE 71 PHILIPPINES: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019-2032 (USD MILLION) 131
TABLE 72 PHILIPPINES: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019-2032 (USD MILLION) 132
TABLE 73 PHILIPPINES: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019-2032 (USD MILLION) 133
TABLE 74 PHILIPPINES: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 134
TABLE 75 PHILIPPINES: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 135
TABLE 76 PHILIPPINES: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 136
TABLE 77 VIETNAM: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 138
TABLE 78 VIETNAM: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019-2032 (USD MILLION) 139
TABLE 79 VIETNAM: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019-2032 (USD MILLION) 140
TABLE 80 VIETNAM: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019-2032 (USD MILLION) 141
TABLE 81 VIETNAM: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019-2032 (USD MILLION) 142
TABLE 82 VIETNAM: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 143
TABLE 83 VIETNAM: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 144
TABLE 84 VIETNAM: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 145
TABLE 85 BANGLADESH: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 147
TABLE 86 BANGLADESH: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019-2032 (USD MILLION) 148
TABLE 87 BANGLADESH: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019-2032 (USD MILLION) 149
TABLE 88 BANGLADESH: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019-2032 (USD MILLION) 150
TABLE 89 BANGLADESH: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019-2032 (USD MILLION) 151
TABLE 90 BANGLADESH: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 152
TABLE 91 BANGLADESH: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 153
TABLE 92 BANGLADESH: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 154
TABLE 93 SRI LANKA: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 156
TABLE 94 SRI LANKA: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019-2032 (USD MILLION) 157
TABLE 95 SRI LANKA: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019-2032 (USD MILLION) 158
TABLE 96 SRI LANKA: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019-2032 (USD MILLION) 159
TABLE 97 SRI LANKA: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019-2032 (USD MILLION) 160
TABLE 98 SRI LANKA: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 161
TABLE 99 SRI LANKA: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 162
TABLE 100 SRI LANKA: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 163
TABLE 101 MAJOR PLAYERS IN THE ASIA CRO MARKET 164
TABLE 102 LIST OF EMERGING CROS IN KEY COUNTRIES 167
TABLE 103 LIST OF DATA MANAGEMENT SOFTWARE USED BY CROS IN ASIA 170
TABLE 104 TOTAL NUMBER OF CLINICAL TRIALS BY PHASE FOR MAJOR ASIA COUNTRIES (2019-2023) 171
TABLE 105 BIBLIOGRAPHY 171
TABLE 106 SYNEOS HEALTH: SERVICE OFFERED 174
TABLE 107 PAREXEL INTERNATIONAL (MA) CORPORATION: SERVICE OFFERED 176
TABLE 108 MEDPACE: SERVICES OFFERED 178
TABLE 109 CMIC HOLDINGS CO., LTD: SERVICES OFFERED 182
TABLE 110 TIGERMED : SERVICES OFFERED 185
TABLE 111 IQVIA HOLDING, INC.: SERVICES OFFERED 188
TABLE 112 ICON PLC: SERVICES OFFERED 191
TABLE 113 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICES OFFERED 195
TABLE 114 PPD INC.: SERVICES OFFERED 198
TABLE 115 WUXI APPTEC: SERVICES OFFERED 201

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 17
FIGURE 2 MARKET STRUCTURE: ASIA CRO MARKET 19
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 24
FIGURE 4 MARKET DYNAMICS: ASIA CRO MARKET 27
FIGURE 5 DRIVER IMPACT ANALYSIS 29
FIGURE 6 RESTRAINT IMPACT ANALYSIS 30
FIGURE 7 ASIA CRO MARKET, SERVICE TYPE SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 42
FIGURE 8 ASIA CRO MARKET, BY SERVICE TYPE, 2022 & 2032 (USD MILLION) 44
FIGURE 9 ASIA CRO MARKET, BY SERVICE TYPE MARKET SHARE (%), BY COUNTRY, 2022 44
FIGURE 10 ASIA CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 46
FIGURE 11 ASIA CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2019-2032 (USD MILLION) 47
FIGURE 12 ASIA CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICES, BY COUNTRY, 2019-2032 (USD MILLION) 48
FIGURE 13 ASIA CRO MARKET, FOR PHARMACOVIGILANCE SERVICES, BY COUNTRY, 2019-2032 (USD MILLION) 49
FIGURE 14 ASIA CRO MARKET, FOR LABORATORY SERVICES, BY COUNTRY, 2019-2032 (USD MILLION) 50
FIGURE 15 ASIA CRO MARKET, FOR CONSULTING SERVICES, BY COUNTRY, 2019-2032 (USD MILLION) 51
FIGURE 16 ASIA CRO MARKET, FOR BIOSTATISTICS SERVICES, BY COUNTRY, 2019-2032 (USD MILLION) 52
FIGURE 17 ASIA CRO MARKET, FOR MEDICAL WRITING SERVICES, BY COUNTRY, 2019-2032 (USD MILLION) 53
FIGURE 18 ASIA CRO MARKET, FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2019-2032 (USD MILLION) 54
FIGURE 19 ASIA CRO MARKET, FOR INTERACTIVE WEB RESPONSE SYSTEMS (IWRS) SERVICES, BY COUNTRY, 2019-2032 (USD MILLION) 55
FIGURE 20 ASIA CRO MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION) 57
FIGURE 21 ASIA CRO MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION) 58
FIGURE 22 ASIA CRO MARKET SHARE (%), BY APPLICATION, 2022 58
FIGURE 23 ASIA CRO MARKET, BY THERAPEUTIC AREA, BY COUNTRY, 2019-2032 (USD MILLION) 60
FIGURE 24 ASIA CRO MARKET, FOR VACCINES, BY COUNTRY, 2019-2032 (USD MILLION) 61
FIGURE 25 ASIA CRO MARKET, FOR ONCOLOGY, BY COUNTRY, 2019-2032 (USD MILLION) 62
FIGURE 26 ASIA CRO MARKET, FOR CARDIOVASCULAR DISORDERS, BY COUNTRY, 2019-2032 (USD MILLION) 63
FIGURE 27 ASIA CRO MARKET, FOR RESPIRATORY, BY COUNTRY, 2019-2032 (USD MILLION) 64
FIGURE 28 ASIA CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY COUNTRY, 2019-2032 (USD MILLION) 65
FIGURE 29 ASIA CRO MARKET, FOR GASTROENTEROLOGY, BY COUNTRY, 2019-2032 (USD MILLION) 66
FIGURE 30 ASIA CRO MARKET, FOR DIABETES, BY COUNTRY, 2019-2032 (USD MILLION) 67
FIGURE 31 ASIA CRO MARKET, FOR AUTO-IMMUNE DISORDERS, BY COUNTRY, 2019-2032 (USD MILLION) 68
FIGURE 32 ASIA CRO MARKET, FOR INFECTIOUS DISEASES, BY COUNTRY, 2019-2032 (USD MILLION) 69
FIGURE 33 ASIA CRO MARKET, FOR OTHERS, BY COUNTRY, 2019-2032 (USD MILLION) 70
FIGURE 34 ASIA CRO MARKET, END USER SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION) 71
FIGURE 35 ASIA CRO MARKET, BY END USER, 2022 & 2032 (USD MILLION) 72
FIGURE 36 ASIA CRO MARKET, BY END USER, 2022 & 2032 (%) 72
FIGURE 37 ASIA CRO MARKET SHARE (%), BY END USER, 2022 73
FIGURE 38 ASIA CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 74
FIGURE 39 ASIA CRO MARKET, FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2032 (USD MILLION) 75
FIGURE 40 ASIA CRO MARKET, FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2019-2032 (USD MILLION) 76
FIGURE 41 ASIA CRO MARKET, FOR ACADEMIC INSTITUTES, BY COUNTRY, 2019-2032 (USD MILLION) 77
FIGURE 42 ASIA CRO MARKET, FOR ACADEMIC INSTITUTES, BY COUNTRY, 2019-2032 (USD MILLION) 78
FIGURE 43 ASIA-PACIFIC MARKET ANALYSIS: CRO MARKET, 2019-2032 (USD MILLION) 80
FIGURE 44 ASIA: CRO MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION) 80
FIGURE 45 ASIA: CRO MARKET, BY COUNTRY, 2022 & 2032 (%) 81
FIGURE 46 ASIA CRO MARKET, BY COUNTRY, 2019-2032 (USD MILLION) 82
FIGURE 47 ASIA: CRO MARKET SHARE (%), BY COUNTRY, 2022 83
FIGURE 48 SOUTH KOREA MARKET ANALYSIS: CRO MARKET, 2019-2032 (USD MILLION) 83
FIGURE 49 SOUTH KOREA: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 84
FIGURE 50 SOUTH KOREA CRO MARKET, BY CLINICAL RESEARCH SERVICES, 2019-2032 (USD MILLION) 85
FIGURE 51 SOUTH KOREA CRO MARKET, FOR FORMULATION DEPLOYMENT SERVICES, 2019-2032 (USD MILLION) 86
FIGURE 52 SOUTH KOREA CRO MARKET, FOR LABORATORY SERVICES, 2019-2032 (USD MILLION) 87
FIGURE 53 SOUTH KOREA CRO MARKET, FOR ANALYTICAL TESTING, 2019-2032 (USD MILLION) 88
FIGURE 54 SOUTH KOREA: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 89
FIGURE 55 SOUTH KOREA CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 90
FIGURE 56 SOUTH KOREA: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 91
FIGURE 57 SINGAPORE MARKET ANALYSIS: CRO MARKET, 2019-2032 (USD MILLION) 92
FIGURE 58 SINGAPORE: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 93
FIGURE 59 SINGAPORE: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019-2032 (USD MILLION) 94
FIGURE 60 SINGAPORE: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019-2032 (USD MILLION) 95
FIGURE 61 SINGAPORE: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE , 2019-2032 (USD MILLION) 96
FIGURE 62 SINGAPORE: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019-2032 (USD MILLION) 97
FIGURE 63 SINGAPORE: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 98
FIGURE 64 SINGAPORE: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 99
FIGURE 65 SINGAPORE: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 100
FIGURE 66 THAILAND MARKET ANALYSIS: CRO MARKET, 2019-2032 (USD MILLION) 101
FIGURE 67 THAILAND: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 102
FIGURE 68 THAILAND: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019-2032 (USD MILLION) 103
FIGURE 69 THAILAND: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019-2032 (USD MILLION) 104
FIGURE 70 THAILAND: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019-2032 (USD MILLION) 105
FIGURE 71 THAILAND: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019-2032 (USD MILLION) 106
FIGURE 72 THAILAND: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 107
FIGURE 73 THAILAND: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 108
FIGURE 74 THAILAND: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 109
FIGURE 75 THAILAND MARKET ANALYSIS: CRO MARKET, 2019-2032 (USD MILLION) 110
FIGURE 76 TAIWAN: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 111
FIGURE 77 TAIWAN: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, 2019-2032 (USD MILLION) 112
FIGURE 78 TAIWAN: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019-2032 (USD MILLION) 113
FIGURE 79 TAIWAN: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019-2032 (USD MILLION) 114
FIGURE 80 TAIWAN: CRO MARKET FOR ANALYTICAL TESTING, BY TYPE, 2019-2032 (USD MILLION) 115
FIGURE 81 TAIWAN: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 116
FIGURE 82 TAIWAN: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 117
FIGURE 83 TAIWAN: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 118
FIGURE 84 MALAYSIA MARKET ANALYSIS: CRO MARKET, 2019-2032 (USD MILLION) 119
FIGURE 85 MALAYSIA: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 120
FIGURE 86 MALAYSIA: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019-2032 (USD MILLION) 121
FIGURE 87 MALAYSIA: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019-2032 (USD MILLION) 122
FIGURE 88 MALAYSIA: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019-2032 (USD MILLION) 123
FIGURE 89 MALAYSIA: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019-2032 (USD MILLION) 124
FIGURE 90 MALAYSIA: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 125
FIGURE 91 MALAYSIA: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 126
FIGURE 92 MALAYSIA: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 127
FIGURE 93 PHILIPPINES MARKET ANALYSIS: CRO MARKET, 2019-2032 (USD MILLION) 128
FIGURE 94 PHILIPPINES: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 129
FIGURE 95 PHILIPPINES: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019-2032 (USD MILLION) 130
FIGURE 96 PHILIPPINES: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019-2032 (USD MILLION) 131
FIGURE 97 PHILIPPINES: CRO MARKET, FORLABORATORY SERVICES, BY TYPE, 2019-2032 (USD MILLION) 132
FIGURE 98 PHILIPPINES: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019-2032 (USD MILLION) 133
FIGURE 99 PHILIPPINES: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 134
FIGURE 100 PHILIPPINES: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 135
FIGURE 101 PHILIPPINES: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 136
FIGURE 102 VIETNAM MARKET ANALYSIS: CRO MARKET, 2019-2032 (USD MILLION) 137
FIGURE 103 VIETNAM: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 138
FIGURE 104 VIETNAM: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019-2032 (USD MILLION) 139
FIGURE 105 VIETNAM: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019-2032 (USD MILLION) 140
FIGURE 106 VIETNAM: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019-2032 (USD MILLION) 141
FIGURE 107 VIETNAM: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019-2032 (USD MILLION) 142
FIGURE 108 VIETNAM: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 143
FIGURE 109 VIETNAM: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 144
FIGURE 110 VIETNAM: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 145
FIGURE 111 BANGLADESH MARKET ANALYSIS: CRO MARKET, 2019-2032 (USD MILLION) 146
FIGURE 112 BANGLADESH: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 147
FIGURE 113 BANGLADESH: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019-2032 (USD MILLION) 148
FIGURE 114 BANGLADESH: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019-2032 (USD MILLION) 149
FIGURE 115 BANGLADESH: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019-2032 (USD MILLION) 150
FIGURE 116 BANGLADESH: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019-2032 (USD MILLION) 151
FIGURE 117 BANGLADESH: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 152
FIGURE 118 BANGLADESH: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 153
FIGURE 119 BANGLADESH: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 154
FIGURE 120 SRI LANKA MARKET ANALYSIS: CRO MARKET, 2019-2032 (USD MILLION) 155
FIGURE 121 SRI LANKA: CRO MARKET, BY SERVICE TYPE, 2019-2032 (USD MILLION) 156
FIGURE 122 SRI LANKA: CRO MARKET, FOR CLINICAL RESEARCH SERVICES, BY TYPE, 2019-2032 (USD MILLION) 157
FIGURE 123 SRI LANKA: CRO MARKET, FOR FORMULATION DEVELOPMENT SERVICE, BY TYPE, 2019-2032 (USD MILLION) 158
FIGURE 124 SRI LANKA: CRO MARKET, FOR LABORATORY SERVICES, BY TYPE, 2019-2032 (USD MILLION) 159
FIGURE 125 SRI LANKA: CRO MARKET, FOR ANALYTICAL TESTING, BY TYPE, 2019-2032 (USD MILLION) 160
FIGURE 126 SRI LANKA: CRO MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 161
FIGURE 127 SRI LANKA: CRO MARKET, FOR CENTRAL NERVOUS SYSTEM, BY TYPE, 2019-2032 (USD MILLION) 162
FIGURE 128 SRI LANKA: CRO MARKET, BY END USER, 2019-2032 (USD MILLION) 163
FIGURE 129 BENCHMARKING OF MAJOR COMPETITORS 165
FIGURE 130 MARKET SHARE ANALYSIS, 2022-2023 (%) 166
FIGURE 131 MAJOR PLAYERS SALES, 2022 166
FIGURE 132 SYNEOS HEALTH: FINANCIAL OVERVIEW SNAPSHOT 173
FIGURE 133 PAREXEL INTERNATIONAL (MA) CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 175
FIGURE 134 PAREXEL INTERNATIONAL (MA) CORPORATION: SWOT ANALYSIS 177
FIGURE 135 MEDPACE: FINANCIAL OVERVIEW SNAPSHOT 178
FIGURE 136 CMIC HOLDINGS CO., LTD: FINANCIAL OVERVIEW SNAPSHOT 181
FIGURE 137 TIGERMED: FINANCIAL OVERVIEW SNAPSHOT 184
FIGURE 138 IQVIA HOLDING, INC.: FINANCIAL OVERVIEW SNAPSHOT 187
FIGURE 139 IQVIA HOLDING, INC.: SWOT ANALYSIS 189
FIGURE 140 ICON PLC: FINANCIAL OVERVIEW SNAPSHOT 190
FIGURE 141 ICON PLC: SWOT ANALYSIS 193
FIGURE 142 LABORATORY CORPORATION OF AMERICA HOLDINGS: FINANCIAL OVERVIEW SNAPSHOT 194
FIGURE 143 LABORATORY CORPORATION OF AMERICA HOLDINGS: SWOT ANALYSIS 196
FIGURE 144 PPD INC.: FINANCIAL OVERVIEW SNAPSHOT 197
FIGURE 145 PPD INC.: SWOT ANALYSIS 199
FIGURE 146 WUXI APPTEC: FINANCIAL OVERVIEW SNAPSHOT 200